HEMISPHERX BIOPHARMA, INC.

Lobbying Spend

—

Filings

Firms Hired

Active Period

2013–2018

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2018	—	3	1
2017	—	4	1
2015	—	2	1
2014	—	3	1
2013	—	5	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
SQUIRE PATTON BOGGS	—	12
PODESTA GROUP, INC.	—	5

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	10
SENATE	10
Food & Drug Administration (FDA)	3
Health & Human Services, Dept of (HHS)	3
Defense, Dept of (DOD)	2
Executive Office of the President (EOP)	2

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	7
Health Issues	Health Issues	7
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	3
Foreign Relations	Foreign Relations	3

HEMISPHERX BIOPHARMA, INC. — Lobbying Disclosure | Poliscope